Colorado Medical Device Firm Zynex Settles DOJ Fraud Case, Signaling Increased Scrutiny of Healthcare Billing
A Colorado-based medical device company, Zynex Inc., has entered into a Non-Prosecution Agreement with the U.S. Department of Justice to resolve allegations of a widespread healthcare fraud scheme. The company, which manufactures devices for pain management and rehabilitation, admitted to overbilling patients and insurers by hundreds of millions of dollars. This case highlights a growing trend of federal crackdowns on fraudulent billing practices within the medical device industry.
The Details of the Zynex Scheme
Zynex admitted to a conspiracy involving healthcare fraud, securities fraud, and mail fraud. Investigators found the company collected over $873 million for its products, with more than $600 million attributed to fraudulent claims, primarily related to medical supplies. The scheme involved shipping and billing for unnecessary supplies in excessive quantities, and misleading investors about these practices.
As part of the agreement, Zynex will pay between $5 million and $12.5 million in penalties, the final amount dependent on its future earnings. The company will also forfeit millions in unpaid claims. Two former top executives, Thomas Sandgaard and Anna Lucsok, were indicted last month and are accused of spearheading the scheme.
Rising Federal Scrutiny of Medical Device Billing
The Zynex case isn’t isolated. Federal authorities are increasingly focused on identifying and prosecuting healthcare fraud, particularly within the durable medical equipment (DME) sector. The Department of Justice has demonstrated a willingness to pursue both companies and individuals involved in these schemes, as evidenced by the indictment of the former Zynex executives.
This increased scrutiny is driven by several factors, including the rising cost of healthcare and the potential for significant financial harm to both patients and insurers. The HHS Office of Inspector General (OIG) plays a crucial role in uncovering these schemes and referring cases for prosecution.
Impact on Patients and the DME Industry
Fraudulent billing practices not only drain resources from the healthcare system but also directly harm patients. Former Zynex employees have reported that patients were often billed for supplies they didn’t need or received excessive shipments of items like electrodes and batteries. Some patients were told the maximum out-of-pocket cost would be $250, only to receive bills in the thousands.
The Zynex case is likely to prompt other medical device companies to review their billing and compliance practices. Enhanced compliance programs and corporate governance reforms, as Zynex has agreed to implement, will become increasingly important for avoiding legal repercussions.
Zynex’s Response and Future Outlook
Zynex’s latest management team, which took over in August 2025, has stated its commitment to rebuilding the company with a focus on compliance. They claim to have overhauled billing and supply replenishment practices and implemented new marketing policies to align with FDA regulations. U.S. Attorney Charles C. Calenda acknowledged the company’s turnaround efforts in the DOJ’s announcement.
Yet, the long-term impact of the scandal on Zynex’s reputation and market position remains to be seen. The company will need to demonstrate a sustained commitment to ethical practices to regain the trust of patients, insurers, and investors.
FAQ
What is a Non-Prosecution Agreement? A Non-Prosecution Agreement (NPA) is an agreement between a prosecutor and a corporation or other entity in which the prosecutor agrees not to pursue criminal charges in exchange for certain commitments from the entity, such as paying penalties and implementing compliance reforms.
What types of fraud were alleged in the Zynex case? The allegations included healthcare fraud, securities fraud, and mail fraud.
What is the role of the Department of Justice in healthcare fraud cases? The DOJ investigates and prosecutes individuals and companies involved in healthcare fraud schemes.
What is the potential penalty for healthcare fraud? Penalties can include fines, forfeiture of assets, and imprisonment.
Did you use Zynex medical devices and believe you were overbilled? The Denver Post is seeking to hear from individuals who may have been affected.
